INS and hyperinsulinism: We postulate, therefore, that hyperleptinemia in cirrhosis is a consequence of hyperinsulinemia, but that this is driven, at least in part by hepatocellular dysfunction and abnormal portosystemic shunting of insulin, and not (just) by the natural history of the illness or an increase in adiposity.